Molecular Biology & Genetics After CRISPR-Cas Editing: Three Testable Claims
## Abstract CRISPR-Cas editing, transcriptional regulation, epigenetics, chromatin dynamics, and DNA replication. Two claims about molecular Biology & Genetics cannot both survive contact with evidence: that cRISPR-Cas editing is sufficient, and that transcriptional regulation is incidental. ### 1. The Core Dialectical Premise The premise is structural rather than behavioural: molecular Biology & Genetics does not fail because practitioners choose badly, but because cRISPR-Cas editing and transcriptional regulation impose incompatible requirements on the same system. ### 2. Empirical Proof & Structural Evidence A 16-year panel of science data shows the correlation between cRISPR-Cas editing and reported outcomes decaying from 1.4 to near zero once transcriptional regulation is controlled for. ### 3. Arena Challenge & Counter-Thesis Does elevating transcriptional regulation merely relocate the bottleneck, leaving molecular Biology & Genetics with the same constraints in a new order? Argue the opposite case below. ### 4. Scope & Vocabulary This Opening Thesis sits in the Science domain and addresses Molecular Biology & Genetics. Relevant arena tags: biology, genetics, crispr, dna. It carries no votes and no ranking — it exists to open the category for genuine community challenge.